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In the general discussion several subjects related to the previously stated 
communications were commented. This report includes the items more that the 
participants considered more interesting as well as the conclusions that reached 
a wide consensus. 
 
 
Among the participants, those who are mentioned hereinafter in alphabetical 
order, actively contributed to the discussion: Virtudes Álvarez Funes, Luis 
Cortina Tarrats, Jesús Domínguez Bueno, Helmut Dubois, René Dybkaer, 
Montse Ferré Masferrer, Josep Maria Gelabert Orench, F. Javier Gella Tomás, 
Joan Guixer Guillem, Javier Hellín del Castillo, Francesc Martos Fernández, 
Roser Mas Serra, Jaume Miró Balagué, Miguel Noblejas Castellanos, Antoni 
Nogueras Brunet, Maite Panadero García, Trevor W. Steele y Maria dels 
Àngels Vernetta Porta. X. Fuentes Arderiu was the moderator. 
 
 
The differences between of some laboratory processes, such as calibration and 
verification, were discussed in full. It was clear that it is very important to use 
the definitions of the International vocabulary of basic and general terms in 
metrology (also known as VIM), published by the International Standard 
Organization (ISO) in 1993, as unique terminological reference to avoid 
mistakes. 
[calibration: set of operations that establish, under specified conditions, the relationship 
between values of quantities indicated by a measuring instrument or measuring system, or 
values represented by a material measure or a reference material, and the corresponding 
values realized by standards (VIM)] 
 
[verification: confirmation, through the provision of objective evidence, that specified 
requirements have been fulfilled (EN ISO 9000:2000)]  
 
 
An approach was made to the differentiation between "instrumental calibration" 
(that refers to the calibration of the parts of an analyser liable of being calibrated 
such as pipettes or wavelength selectors) and "metrological calibration of the 
analysers" (which refers to the usual calibration performed at regular intervals to 
make the measurements). Since an analyser is a measurement system that can 
include several devices liable to calibration, there was a general agreement to 
consider that when a measurement system (analyser) is calibrated in the clinical 
laboratory, the global calibration of all the parts involved in the expected 
measurement is being performed. Therefore, with regard to the analysers, in a 
certification or accreditation process only this calibration should be requested. 
 
 
Further on it was clarified that according to the document Guide to the 
expression of uncertainty in measurements (also known as GUM), published by 
the ISO in 1993, the estimation of the uncertainty is not the estimation of the 
measurement error (called "total error" in the texts that do not follow the 
terminology recommended by the ISO) but the estimation of the standard 
uncertainties generated by each one of the sources of uncertainty affecting a 
certain measurement procedure. 
 
 
There was a long discussion about the validation of the software programs both 
of those that constitute a lab information system and of those that are part of the 
software system of an analyser. The existence of any standard related to this 
subject was not identified [nevertheless, information concerning this matter can 
be found in the web <http://www.labcompliance.com/index.htm>]. It was pointed 
out that the differences existing among the computer algorithms used for the 
calculation of the results of the measurement systems based on 
immunochemical procedures can be an important source of uncertainty of 
measurement. 
 
 
Concerning the validation of the analysers, of the computer systems and of the 
in vitro diagnostic products in general, after a long and intense discussion, the 
widespread conclusion was reached that to consider a product as validated, the 
following requirements should be fulfilled: the specifications of the in vitro 
diagnostic products have to satisfy the customer requirements, these in vitro 
diagnostic products should be manufactured according to the Directive 98/79 
CE and the manufacturer should be certified according to the ISO 9001 
standard. Thus, it will be enough a report submitted by the manufacturer to the 
customer stating the verifications carried out in order to check that the transfer 
and the installation of the product, if appropriate, have not modified its 
specifications. 
 
 
It was admitted that, in spite of the fact that the Directive 98/79 CE requires that, 
whenever it is appropriate, the analytic specificity of the in vitro diagnostic 
products is studied, it is very difficult that this study is carried out taking into 
consideration a high number of possible interferents. As for the medicines, it 
would be necessary to study all the interferences that the drugs commonly 
administered to treat a certain disease may cause to the procedure in issue. 
 
 
Finally, the old problem of the production of reference values was discussed. 
Two well differentiated positions were held: While one position defended that 
the standard does not require from the industry the production of reference 
values appropriate for each biologically homogeneous population to which the 
diagnostic procedure has to be applied, the other one maintained that the spirit 
of the standard is just the opposite. The discussion concluded reminding that a 
way to solve this conflict easily is to carry out co-operative projects between the 
in vitro diagnostic industry and several clinical laboratories to produce 
multicentric reference values, just as some recent experiences have proved. 
[Clin Chem Lab Med 2000;38:1013-9; Clin Chim Acta 2001;304:143-6; Clin 
Chem Lab Med 2001;39:166-9; Scand J Clin Lab Invest 2001; not published 
yet]. 
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